I. Argles

Marked and rapid effects of pharmacological HIF-2α antagonism on hypoxic ventilatory control

P. Robbins, L. Collinson, P. Ratcliffe, 2020, The Journal of clinical investigation.

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers

G. Rodger, M. Gates, J. Dequaire, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells

Alfredo Castello, P. Ratcliffe, J. McKeating, 2020, Cell Reports.